Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
8.60
0.00
(0.00%)
At close: February 28 at 3:00:00 PM EST
Breakdown
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Assets
247,970
43,267
40,056
24,953
Total Liabilities Net Minority Interest
42,763
1,678
803
753
Total Equity Gross Minority Interest
205,207
41,589
39,253
24,200
Total Capitalization
205,207
41,589
39,253
24,200
Common Stock Equity
205,207
41,589
39,253
24,200
Net Tangible Assets
205,207
41,589
39,253
24,200
Working Capital
204,393
41,568
39,241
24,190
Invested Capital
205,207
41,589
39,253
24,200
Tangible Book Value
205,207
41,589
39,253
24,200
Share Issued
129,665.68
128,965.68
128,965.68
117,608.11
Ordinary Shares Number
129,665.68
128,965.68
128,965.68
117,608.11
12/31/2020 - 11/4/2009
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
VALN Valneva SE
6.75
-5.20%
VRDN Viridian Therapeutics, Inc.
15.53
+1.57%
CHRO Channel Therapeutics Corporation
2.0500
0.00%
NGNE Neurogene Inc.
17.69
+3.45%
ASND Ascendis Pharma A/S
156.58
+2.25%
MRUS Merus N.V.
47.09
+1.88%
KALV KalVista Pharmaceuticals, Inc.
11.40
+6.59%
IGC IGC Pharma, Inc.
0.2900
+2.80%
TELO Telomir Pharmaceuticals, Inc.
4.0000
+2.30%
SCPH scPharmaceuticals Inc.
3.2800
+1.23%